FindTrial
Sign In

Comparison of 1.25mg, 0.75mg, 0.54mg GnRH-agonist for Long-protocol of Controlled Ovarian Stimulation in IVF/ICSI

Comparison of 1.25mg, 0.75mg, 0.54mg GnRH-agonist for Long-protocol of Controlled Ovarian Stimulation in IVF/ICSI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001341
Enrollment
Unknown
Registered
2011-05-04
Start date
2010-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

1:receiving 1.25mgGnRH-a
2:receiving 0.75mgGnRH-a group B
3:receiving 0.75mgGnRH-a group B

Sponsors

Sun-yat Sen Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Infertility females, age<=35 years; 2. With indication for cycle of IVF/ICSI/TESA/PESA; 3. Undergo long protocol IVF/ICSI/TESA/PESA; 4. Have regular menstruation; 5. 16kg/m2<=BMI <=25kg/m2; 6. Basic serum FSH level<12IU/L.

Exclusion criteria

Exclusion criteria: 1. Patients with PCOS; 2. Patients with chromosome abnormality; 3. Patients with untreated endometriosis; 4. Patients with untreated endometrial lesions; 5. Patients with obvious hydrosalpinx.

Design outcomes

Primary

MeasureTime frame
premature LH surge rate;—

Secondary

MeasureTime frame
pregnancy rate;live-birh rate;spontaneous early abortion rate;—

Countries

China

Contacts

Public ContactQing-xue ZHANG
zhangqingxue666@yahoo.cn+86 20 81332233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026